This study aimed to evaluate the effects of barley flour, crude cinnamon, and their combination on blood glucose, serum insulin, serum lipid profile, and serum adipose tissue hormones in streptozotocin-induced diabetic rats. Male Wistar rats (n=35) were divided into five groups: nondiabetic, diabetic, diabetic group fed 5% cinnamon, diabetic group fed 30% barley, and diabetic group fed 5% cinnamon and 30% barley. Fasting blood glucose, insulin, lipid profile, adiponectin, and leptin were measured after 8 weeks. Blood glucose significantly decreased in all treated diabetic rats compared with the diabetic group. Serum insulin and high-density lipoprotein significantly increased, while cholesterol, triglycerides, and low-density lipoprotein were significantly decreased after 8 weeks. Adiponectin significantly increased, while leptin significantly decreased with administration of either cinnamon, barley, or their combination. No significant differences were observed among the three treated groups on all parameters. A cinnamon and barley combination caused obvious improvement in insulin-positive cells of pancreatic tissue. In conclusion, consuming diets containing either cinnamon, barley, or their combination regulates blood glucose, lipid profile, and adipose tissue hormones in type 2 diabetic rats. The most effective treatment was the cinnamon and barley combination.
Al-MaatouqM, Al-AroujM, AssaadSH, AssaadSN, AzarST, HassounAA, JarrahN, ZatariS, AlbertiKG. Optimising the medical management of hyperglycaemia in type 2 diabetes in the Middle East: pivotal role of metformin. Inter J Clin Pract, 2010; 64:149–159.
3.
WangHJ, JinYX, ShenW, NengJ, WuT, LiYJ, FuZW. Low dose streptozotocin (STZ) combined with high energy intake can effectively induce type 2 diabetes through altering the related gene expression. Asia Pac J Clin Nutr, 2007; 116:412–417.
HongH, JaiWM. Effects of malted barley extract and banana extract on blood glucose levels in genetically diabetic mice. J Med Food, 2004; 7:487–490.
6.
HinataM, OnoM, MidorikawaS, NakanishiK. Metabolic improvement of male prisoners with type 2 diabetes in Fukushima Prison, Japan. Diabetes Res Clin Prac, 2007; 77:327–332.
7.
IzydorczykMS, DexterJE. Barley β-glucans and arabinoxylans: molecular structure, physicochemical properties and uses in food products—a review. Food Res Int, 2008; 41:850–868.
8.
KimH, StoteKS, BehallKM, SpearsK, VinyardB, ConwayJM. Glucose and insulin responses to whole grain breakfasts varying in soluble fiber, beta-glucan: a dose response study in obese women with increased risk for insulin resistance. Eur J Nutr, 2009; 48:170–175.
9.
KimSH, HyunSH, ChoungSY. Anti-diabetic effect of cinnamon extract on blood glucose in db/db mice. J Ethnopharmacol, 2006; 104:119–123.
10.
BroadhurstCL, PolanskyMM, AndersonRA. Insulin-like biological activity of culinary and medicinal plant aqueous extracts in vitro. J Agric Food Chem, 2000; 48:849–852.
11.
Harlan Laboratories, Inc.Teklad lab animal diets. www.harlan.com/products_and_services/research_models_and_services/laboratory_animal_diets. 2011 January 28.
12.
ZhangM, LvXY, LiJ, XuZG, ChenL. The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Exp Diabetes Res, 2008; 2008:1–9.
SrinivasanK, ViswanadB, AsratL, KaulCL, RamaraoP. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res, 2005; 52:313–320.
15.
SahinK, OnderciM, TuzcuM, UstundagB, CikimG, OzercanIH, SriramojuV, JuturuV, KomorowskiJR. Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat. Metabolism, 2007; 56:1233–1240.
16.
TonyushkinaK, NicholsJH. Glucose meters: a review of technical challenges to obtaining accurate results. J Diabetes Sci Technol, 2009; 3:971–980.
17.
SchettlerG, NusselE. Enzymatic calorimetric determination of high density lipoprotein cholesterol by CHOD-PAP method. Arb Med Soz Med Prov Med, 1975; 10:25.
18.
OkadaM, MatsuiH, ItoY. Low-density lipoprotein cholesterol can be chemically measured: a new superior method. J Lab Clin Med, 1998; 132:195–201.
19.
IzawaS, OkadaM, MatsuiH, HoritaYA. New direct method for measuring HDL cholesterol which does not produce any biased values. J Med Pharm Sci, 1997; 137:1385–1388.
20.
FurutaM, CarrollR, MartinS, SwiftHH, RavazzolaM, OrciL, SteinerDF. Incomplete processing of pro-insulin to insulin accompanied by elevation of des-31,32 proinsulin intermediates in islets of mice lacking active PC2. J Biol Chem, 1998; 273:3431–3437.
SchererPE, WilliamsS, FoglianoM, BaldiniG, LodishHF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem, 1995; 270:26746–26749.
YamacM, ZeytinogluM, KanbakG, BayramogluG, SenturkH. Hypoglycemic effect of crude exopolysaccharides produced by Cerrena unicolor, Coprinus comatus, and Lenzites betulina isolates in streptozotocin-induced diabetic rats. Pharm Biol, 2009; 47:168–174.
25.
LeeJS, SonHS, MaengYS, ChangYK, JuJS. Effect of buckwheat on organ weight, glucose and lipid metabolism in streptozotocin-induced diabetic rats. Korean J Nutr, 1994; 27:819–827.
26.
RousselAM, HiningerI, BenarabaR, ZiegenfussTN, AndersonRA. Antioxidant effects of a cinnamon extract in people with impaired fasting glucose that are overweight or obese. J Am Coll Nutr, 2009; 28:16–21.
27.
AkilenR, TsiamiA, DevendraD, RobinsonN. Glycated haemoglobin and blood pressure-lowering effect of cinnamon in multi-ethnic Type 2 diabetic patients in the UK: a randomized, placebo-controlled, double-blind clinical trial. Diabet Med, 2010; 27:1159–1167.
28.
HlebowiczJ, DarwicheG, BjorgellO, AlmerLO. Effect of cinnamon on postprandial blood glucose, gastric emptying, and satiety in healthy subjects. Am J Clin Nutr, 2007; 85:1552–1556.
29.
PingH, ZhangG, RenG. Antidiabetic effects of cinnamon oil in diabetic KK-Ay mice. Food Chem Toxicol, 2010; 48:2344–2349.
30.
HaghighianHK, NaimiAF, GargariBP, AsgharzadehAA, NematiA. Effect of cinnamon supplementation on blood glucose and lipid levels in type 2 diabetic patients. J Paramed Sci, 2011; 2ISSN2008–4978.
31.
KimSH, ChoungSY. Antihyperglycemic and antihyperlipidemic action of Cinnamomi cassiae (Cinnamon bark) extract in C57BL/Ks db/db mice. Arch Pharm Res, 2010; 33:325–333.
32.
ChenJ, RaymondK. Beta-glucans in the treatment of diabetes and associated cardiovascular risks. Vasc Health Risk Manag, 2008; 4:1265–1272.
33.
SakumaM, Yamanaka-OkumuraH, NaniwaY, MatsumotoD, TsunematsuM, YamamotoH, TaketaniY, TakedaE. Dose-dependent effects of barley cooked with white rice on postprandial glucose and desacyl ghrelin levels. J Clin Biochem Nutri, 2009; 44:151–159.
34.
NilssonAC, OstmanEM, HolstJJ, BjörckIM. Including indigestible carbohydrates in the evening meal of healthy subjects improves glucose tolerance, lowers inflammatory markers, and increases satiety after a subsequent standardized breakfast. J Nutr, 2008; 138:732–739.
35.
BridgesSR, AndersonJW, DeakinsDA, WoodCA. Oat bran increases serum acetate of hypercholesterolemic men. Am J Clin Nutr, 1992; 56:455–459.
36.
RobertsonMD, BickertonAS, DennisAL, VidalH, FraynKN. Insulin sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. Am J Clin Nutr, 2005; 82:559–567.
37.
KimSP, CatalanoKJ, HsuIR, ChiuJD, RicheyJM, BergmanRN. Nocturnal free fatty acids are uniquely elevated in the longitudinal development of dietinduced insulin resistance and hyperinsulinemia. Am J Physiol Endocrinol Metab, 2007; 292:E1590–E1598.
38.
YousefMI, HarounM, El-MasryMH, AteiaRE. Biochemical and immunological study on the effects of barley and it components as hypoglycemic agents in diabetic rats. Am Biochem Biotech, 2006; 2:1–8.
39.
VincentJB. Elucidating a biological role for chromium at a molecular level. Acc Chem Res, 2000; 33:503–510.
40.
CasiraghiMC, GarsettiM, TestolinG, BrighentiF. Post-prandial responses to cereal products enriched with barley beta-glucan. J Am Coll Nutr, 2006; 25:313–320.
41.
ModiKP, VishwakarmaSL, GoyalRK, BhattPA. Beneficial effects of coenzyme Q10 in streptozotocin-induced type I diabetic rats. Iran J Pharmacol Ther, 2006; 5:61–65.
42.
MooradianAD. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab, 2009; 5:150–159.
43.
ReddyJK, HashimotoT. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Annu Rev Nutr, 2001; 21:193–230.
44.
KeoghGF, CooperGJ, MulveyTB, McArdleBH, ColesGD, MonroJA, PoppittSD. Randomized controlled crossover study of the effect of highly beta-glucan enriched barley on cardiovascular disease risk factors in mildly hypercholesterolemic men. Am J Clin Nutr, 2003; 78:711–718.
45.
QueenanKM, StewartML, SmithKN, ThomasW, FulcherRG, SlavinJL. Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutr J, 2007; 6:1–8.
46.
AnderssonM, EllegårdL, AnderssonH. Oat bran stimulates bile acid synthesis within 8 h as measured by 7alpha-hydroxy-4-cholesten-3-one. Am J Clin Nutr, 2002; 76:1111–1116.
47.
KadowakiT, YamauchiT, KubotaN, HaraK, UekiK, TobeK. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest, 2006; 116:1784–1792.
48.
DuncanBB, SchmidtMI, PankowJS, BangH, CouperD, BallantyneCM, HoogeveenRC, HeissG. Adiponectin and the development of type 2 diabetes: the Atherosclerosis Risk in Communities Study. Diabetes, 2004; 53:2473–2478.
49.
HardieDG. The AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology, 2003; 144:5179–5183.
50.
ShimabukuroM, HigaN, AsahiT, OshiroY, TakasuN, TagawaT, UedaS, ShimomuraI, FunahashiT, MatsuzawaY. Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab, 2003; 88:3236–3240.
51.
MiyazakiY, MahankliA, MatsudaM, GlassL, MahankaliS, FerranniniE, CusiK, MandarinoLJ, DeFronzoRA. Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone. Diabetes Care, 2001; 24:710–719.
52.
DelporteML, El MkademSA, QuisquaterM, BrichardSM. Leptin treatment markedly increased plasma adiponectin but barely decreased plasma resistin of ob/ob mice. Am Physiol Endocrinol Metab, 2004; 287:E446–E453.
53.
BelobrajdicDP, LamYY, ManoM, WittertGA, BirdAR. Cereal based diets modulate some markers of oxidative stress and inflammation in lean and obese Zucker rats. Nutr Metab, 2011; 8:27.
54.
SzkudelskiT. The mechanism of alloxan and streptozotocin action in β cells of the rat pancreas. Physiol Res, 2001; 50:537–546.
